Johnson & Johnson MedTech Introduces Innovative Shockwave Catheter for Intravascular Lithotripsy
Johnson & Johnson MedTech has recently unveiled an innovative Shockwave catheter aimed at enhancing intravascular lithotripsy (IVL) treatments.
This groundbreaking catheter has received FDA clearance and is engineered to optimize treatment outcomes for patients suffering from calcified lesions.
The introduction of this catheter marks a significant milestone in medical technology, promising to improve patient care and addressing a critical need in the field of cardiology.
Healthcare professionals now have access to enhanced tools that can lead to better procedural results and overall patient satisfaction.
For more details, visit the source.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.